
AI Designs High-Potency CRISPR Inhibitors in Eight Weeks
A breakthrough in AI-driven molecular design has accelerated the creation of potent CRISPR inhibitors, compressing what once took months into weeks. This advancement reshapes the competitive landscape for gene-editing therapeutics.








